Beginning investigators
The ACSBI fellowship emphasizes the transfer of knowledge from the host institute to others at the home institute. It offers the fellow the opportunity to be mentored by experts in the chosen field, receive hands on experience in clinical, behavioural or basic research, intellectual stimulation, research guidance, narrative transfer and many other opportunities to evolve scientifically and academically.
The goals include not only developing future leaders in cancer research in low/middle income countries, but also facilitating a global effort in cancer prevention and control. This will be done by developing the necessary intellectual infrastructure in home countries (since ACSBI fellows must return to their home institute), encouraging collaborative interactions to facilitate interdisciplinary basic and applied cancer research, and establishing a network of researchers and translational scientists for rapid dissemination of new knowledge and technology in developing and sharing of best practices.
Since its inception, the ACSBI fellowships have contributed to the development of the professional capacity of over 450 Fellows from over 63 countries.
- Click here to apply -
Target candidates |
Strong preference will be given to research investigators, clinician scientist, epidemiologists, public health professionals from low-, lower-middle- and upper-middle-income countries, as defined by the World Bank. |
Duration |
12 months |
| Extension | Up to 12 months with funding secured by the fellow from other sources and at no cost to the UICC |
| Available | 6-8 per year |
| Value | US $50,000 each for travel and stipend |
| Application closing date | 1 November |
| Notification of result | April the following year |
| 2013 results | Click here to read the fellowship award recipients list |
Objectives |
|
Goals |
|
Eligibility |
|
Research plan |
|
Annual competitive selection is conducted by an international panel of experts based on:
- the scientific evaluation of the research plan
- the experience and qualifications of the candidate
- the suitability of the host organization and host supervisor
- appropriate duration
- a telephone interview with the candidate
- the availability of appropriate facilities and resources to apply and disseminate the acquired skills upon return to the home organization
Note: This is not a clinical training fellowship
Unsolicited applications will not be accepted from, nor will fellowships be awarded for, the support of research conducted at for-profit institutions nor will any projects concerning human embryonic stem cells or human fetal stem cells and tissue be funded by ACS.
*Definitions
Terminal degree: is generally accepted as the highest degree in a field of study. An earned academic (or research) doctorate such as a Doctor of Philosophy is considered the terminal degree in most academic fields of study in some countries. Many professional degrees are also considered terminal degrees because they are the highest professional degree in the field, even though "higher" research degrees exist.
Applied research: is directed towards achieving specific objectives such as the development of a new drug, diagnostic test or procedure, therapy, or surgical procedure. It involves the application of existing knowledge, much of which is obtained through basic research, to a specific biomedical problem. It can be conducted with animals, non-animal alternatives such as computer models or tissue cultures, or with humans.
Clinical research: builds upon knowledge learned through basic and applied research, and is conducted on human beings, usually in a hospital, clinical or community setting. The knowledge obtained from this research results in establishing treatments and drugs, psychosocial and behavioral interventions, or policy changes that directly improve human health, quality of life or healthcare delivery.
Translational Research: is the translation of novel findings obtained from basic research laboratories into testable hypotheses for evaluation in clinical trials in human subjects.
Supporters
